These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 8092025

  • 1. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
    Fujita T, Ito K, Choji T, Honjo K, Matsumoto T, Arita T, Nakanishi T.
    AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025
    [No Abstract] [Full Text] [Related]

  • 2. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A, Aznar L, Alamar R, Castelló JV.
    Med Clin (Barc); 1996 Feb 10; 106(5):197. PubMed ID: 8684023
    [No Abstract] [Full Text] [Related]

  • 3. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
    Strouse PJ, Prince MR, Chenevert TL.
    Radiology; 1996 Dec 10; 201(3):809-16. PubMed ID: 8939236
    [Abstract] [Full Text] [Related]

  • 4. Sonographic guidance of needle position for MR arthrography of the shoulder.
    Valls R, Melloni P.
    AJR Am J Roentgenol; 1997 Sep 10; 169(3):845-7. PubMed ID: 9275909
    [No Abstract] [Full Text] [Related]

  • 5. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector.
    Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC.
    Radiology; 1997 Jan 10; 202(1):268-73. PubMed ID: 8988222
    [Abstract] [Full Text] [Related]

  • 6. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
    Peterson MS, Baron RL, Murakami T.
    Radiology; 1996 Nov 10; 201(2):337-45. PubMed ID: 8888220
    [Abstract] [Full Text] [Related]

  • 7. Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions.
    Quillin SP, Atilla S, Brown JJ, Borrello JA, Yu CY, Pilgram TK.
    Magn Reson Imaging; 1997 Nov 10; 15(3):275-85. PubMed ID: 9201674
    [Abstract] [Full Text] [Related]

  • 8. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
    Vogl TJ, Mack MG, Juergens M, Stark M, Pegios W, Bergman C, Grevers G, Western A.
    AJR Am J Roentgenol; 1994 Aug 10; 163(2):425-32. PubMed ID: 8037044
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
    Ros PR, Gauger J, Stoupis C, Burton SS, Mao J, Wilcox C, Rosenberg EB, Briggs RW.
    AJR Am J Roentgenol; 1995 Dec 10; 165(6):1447-51. PubMed ID: 7484583
    [Abstract] [Full Text] [Related]

  • 10. Fibrolamellar hepatocellular carcinoma: MR appearance mimicking focal nodular hyperplasia.
    Hamrick-Turner JE, Shipkey FH, Cranston PE.
    J Comput Assist Tomogr; 1994 Dec 10; 18(2):301-4. PubMed ID: 8126288
    [Abstract] [Full Text] [Related]

  • 11. Basic analysis of dynamic study in cases of hepatocellular carcinoma using inversion recovery snap shot FLASH MR imaging with Gd-DTPA.
    Suto Y, Kamba M, Kato T, Ohta Y.
    Radiat Med; 1995 Dec 10; 13(2):89-94. PubMed ID: 7667515
    [Abstract] [Full Text] [Related]

  • 12. Gadopentetate dimeglumine as an alternative contrast material for use in angiography.
    Kinno Y, Odagiri K, Andoh K, Itoh Y, Tarao K.
    AJR Am J Roentgenol; 1993 Jun 10; 160(6):1293-4. PubMed ID: 8388622
    [No Abstract] [Full Text] [Related]

  • 13. Clinical safety of gadopentetate dimeglumine.
    Nelson KL, Gifford LM, Lauber-Huber C, Gross CA, Lasser TA.
    Radiology; 1995 Aug 10; 196(2):439-43. PubMed ID: 7617858
    [Abstract] [Full Text] [Related]

  • 14. Lumbosacral spine: early and delayed MR imaging after administration of an expanded dose of gadopentetate dimeglumine in healthy, asymptomatic subjects.
    Jinkins JR, Rauch RA, Gee GT, Bazan C, Xiong L, Kashanian FK, Hanna EP.
    Radiology; 1995 Oct 10; 197(1):247-51. PubMed ID: 7568831
    [Abstract] [Full Text] [Related]

  • 15. In vivo target-specific delivery of macromolecular agents with MR-guided focused ultrasound.
    Bednarski MD, Lee JW, Callstrom MR, Li KC.
    Radiology; 1997 Jul 10; 204(1):263-8. PubMed ID: 9205257
    [Abstract] [Full Text] [Related]

  • 16. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
    Tishler S, Hoffman JC.
    AJNR Am J Neuroradiol; 1990 Jul 10; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging.
    Murakami T, Nakamura H, Tsuda K, Nakanishi K, Hori S, Tomoda K, Mitani T, Kozuka T, Monden M, Wakasa K.
    AJR Am J Roentgenol; 1993 Feb 10; 160(2):295-9. PubMed ID: 8380948
    [Abstract] [Full Text] [Related]

  • 18. Dose of contrast material in the MR imaging evaluation of central nervous system tumors.
    Yuh WT, Halloran JI, Mayr NA, Fisher DJ, Nguyen HD, Simonson TM.
    J Magn Reson Imaging; 1994 Feb 10; 4(3):243-9. PubMed ID: 8061421
    [No Abstract] [Full Text] [Related]

  • 19. Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: correlation with histopathologic findings.
    Yamashita Y, Fan ZM, Yamamoto H, Matsukawa T, Yoshimatsu S, Miyazaki T, Sumi M, Harada M, Takahashi M.
    J Magn Reson Imaging; 1994 Feb 10; 4(1):83-90. PubMed ID: 8148562
    [Abstract] [Full Text] [Related]

  • 20. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
    Jung HW, Chang KH, Choi DS, Han MH, Han MC.
    AJR Am J Roentgenol; 1995 Nov 10; 165(5):1251-5. PubMed ID: 7572513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.